Literature DB >> 1672875

A comparative analysis of the distribution of prosomatostatin-derived peptides in human and monkey neocortex.

T L Hayes1, J L Cameron, J D Fernstrom, D A Lewis.   

Abstract

Comparative analyses were made of the immunohistochemical and biochemical distributions of three prosomatostatin-derived peptides (PSDP) in human, perfused monkey, and unperfused monkey neocortex. The PSDP we examined were the tetradecapeptide somatostatin 14 (SS14); the N-terminal extension of this peptide, somatostatin 28 (SS28); and somatostatin 28(1-12) (SS28(1-12)). In immunohistochemical experiments, numerous SS28-immunoreactive perikarya were located in both superficial and deep layers of perfused monkey cortex, but none were present in the cerebral cortex from unperfused monkey or autopsied human brains. In contrast, the number of SS28(1-12)-immunoreactive neurons was five times greater in the superficial cortical layers of unperfused monkey than of perfused monkey brain. Moreover, unperfused monkey and human cortex contained notably more SS14-immunoreactive processes than perfused monkey cortex. These data suggested that SS28 may have been converted into SS14 and SS28(1-12) in unperfused tissue during the post-mortem interval. This hypothesis was examined biochemically by measuring the levels of immunoreactivity of SS14, SS28, and SS28(1-12) in samples of unperfused monkey cortex frozen at different time intervals after removal from the brain. Samples frozen 10 minutes or longer after removal contained only 10-20% the level of SS28 immunoreactivity measured in samples frozen immediately or 1 minute after removal. The levels of SS14 and SS28(1-12) immunoreactivity did not demonstrate such reductions, and may instead have increased at early time points. To further characterize post-mortem effects on PSDP and to explore for species differences, we performed a detailed comparison of the regional, laminar, and cellular distribution of SS28(1-12) immunoreactivity under the three conditions. A progressive loss of immunoreactivity, particularly in radial fibers, was found at increasing post-mortem intervals in unperfused monkey neocortex, indicating that differences in density and distribution of immunoreactive fibers between human and perfused monkey may result from post-mortem peptide degradation in unperfused tissue. In contrast, the larger size of SS28(1-12)-immunoreactive white matter neurons in humans as compared to monkeys appeared partially due to a post-mortem effect but also reflected a species difference. In addition, the density of white matter neurons was found to be significantly greater in human than in perfused or unperfused monkey. These data indicate that any study of human autopsy material must be assessed in light of possible post-mortem effects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672875     DOI: 10.1002/cne.903030406

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  11 in total

1.  Laser capture microdissection-targeted mass spectrometry: a method for multiplexed protein quantification within individual layers of the cerebral cortex.

Authors:  Matthew L MacDonald; Daley Favo; Megan Garver; Zhe Sun; Dominique Arion; Ying Ding; Nathan Yates; Robert A Sweet; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2018-11-02       Impact factor: 7.853

2.  GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders.

Authors:  Etienne Sibille; Harvey M Morris; Rama S Kota; David A Lewis
Journal:  Int J Neuropsychopharmacol       Date:  2011-07       Impact factor: 5.176

3.  Reduced somatostatin in subgenual anterior cingulate cortex in major depression.

Authors:  Adam Tripp; Rama S Kota; David A Lewis; Etienne Sibille
Journal:  Neurobiol Dis       Date:  2011-01-11       Impact factor: 5.996

4.  Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia.

Authors:  Dominique Arion; David A Lewis
Journal:  Arch Gen Psychiatry       Date:  2010-09-06

5.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.

Authors:  T Hashimoto; D Arion; T Unger; J G Maldonado-Avilés; H M Morris; D W Volk; K Mirnics; D A Lewis
Journal:  Mol Psychiatry       Date:  2007-05-01       Impact factor: 15.992

6.  Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder.

Authors:  Harvey M Morris; Takanori Hashimoto; David A Lewis
Journal:  Cereb Cortex       Date:  2008-01-17       Impact factor: 5.357

Review 7.  Biological substrates underpinning diagnosis of major depression.

Authors:  Etienne Sibille; Beverly French
Journal:  Int J Neuropsychopharmacol       Date:  2013-05-14       Impact factor: 5.176

8.  Dendritic-targeting GABA neurons in monkey prefrontal cortex: comparison of somatostatin- and calretinin-immunoreactive axon terminals.

Authors:  Darlene S Melchitzky; David A Lewis
Journal:  Synapse       Date:  2008-06       Impact factor: 2.562

9.  Expression of Transcripts Selective for GABA Neuron Subpopulations across the Cortical Visuospatial Working Memory Network in the Healthy State and Schizophrenia.

Authors:  Makoto Tsubomoto; Rika Kawabata; Xiaonan Zhu; Yoshio Minabe; Kehui Chen; David A Lewis; Takanori Hashimoto
Journal:  Cereb Cortex       Date:  2019-07-22       Impact factor: 5.357

Review 10.  Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia.

Authors:  Jason Smucny; Samuel J Dienel; David A Lewis; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2021-07-20       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.